Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ADAM10 | O14672 | 4/20 | 0.31 |
| ▸ | MMP2 | P08253 | 4/20 | 0.31 |
| ▸ | MMP1 | P03956 | 2/20 | 0.30 |
| ▸ | MMP3 | P08254 | 2/20 | 0.30 |
| ▸ | MMP9 | P14780 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8278899 | 0.99 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL3968541 | 0.99 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL8277043 | 0.99 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL3969376 | 0.99 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL8278252 | 0.97 | ADRB3 (0.41) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL13892488 | 0.97 | ADRB3 (0.41) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL3969646 | 0.97 | ADRB3 (0.41) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL3969673 | 0.95 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL13892479 | 0.95 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS | |
| SCHEMBL13892448 | 0.95 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1680137-B1 | Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication | HOFFMANN LA ROCHE (CH) | 2012-11-21 | — | — | EP | disclosed |